B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 6.45 NOK -11.19% Market Closed
Market Cap: 261.9m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bergenbio ASA
Operating Income Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Operating Income
-kr162.2m
CAGR 3-Years
20%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Operating Income
-kr120.4m
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-14%
L
Lytix Biopharma AS
OSE:LYTIX
Operating Income
-kr96.8m
CAGR 3-Years
-32%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Operating Income
kr7.9m
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Operating Income
-$58.9m
CAGR 3-Years
N/A
CAGR 5-Years
-64%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Operating Income
-kr20.3m
CAGR 3-Years
63%
CAGR 5-Years
44%
CAGR 10-Years
7%

See Also

What is Bergenbio ASA's Operating Income?
Operating Income
-162.2m NOK

Based on the financial report for Jun 30, 2024, Bergenbio ASA's Operating Income amounts to -162.2m NOK.

What is Bergenbio ASA's Operating Income growth rate?
Operating Income CAGR 5Y
3%

Over the last year, the Operating Income growth was 37%. The average annual Operating Income growth rates for Bergenbio ASA have been 20% over the past three years , 3% over the past five years .

Back to Top